FDA MedWatch - Methylin CT [Methylphenidate HCl Chewable Tablets] recall due to exces

  1. MedWatch - The FDA Safety Information and Adverse Event Reporting Program

    FDA and Alliant Pharmaceuticals notified healthcare professionals and
    consumers of the voluntary recall of one lot of Methylphenidate HCl Chewable
    Tablets, 5 mg strength,indicated for Attention Deficit Hyperactivity
    Disorder and Narcolepsy. After testing and evaluation, Alliant found that
    lot number #AMT50402A [expiration date April 2006] might contain up to three
    times the active ingredient, and elected to recall the medication as it
    could pose serious health risk for some patients.

    Read the MedWatch 2005 safety summary, including links to the Firm Press
    Release, at:

  2. Visit Brian profile page

    About Brian, ADN

    Joined: Mar '98; Posts: 15,432; Likes: 16,403
    allnurses.com founder; from US
    Specialty: 18+ year(s) of experience in CCU, Geriatrics, Critical Care, Tele